CPD: Immunological products and vaccines

Ivstiv/iStockphoto.com

Articles in this section reflect chapter 14 of the British National Formulary and relate to immunological products and vaccines

Organ transplantation

For over 50 years those who experience vital organ failure have had a chance to live relatively normal lives thanks to transplant surgery. However, the shortfall between recipients and donors continues to rise. Patients who tolerate a transplanted organ without the need for pharmacological intervention are few and far between. Several immunosuppressants can be used to reduce the risk of organ rejection

• Organ transplantation: Donation and surgery
• Organ transplantation: Immunosuppression

Hepatitis B

Some 350 million people across the world are infected chronically with hepatitis B. Despite global control of the disease being achievable through widespread vaccination, this has not yet been attained. Peginterferon alfa and antiviral drugs are the mainstay of chronic hepatitis B therapy

• Hepatitis B: Diagnosis and monitoring
• Hepatitis B: Management

Vaccination services: a new era?

In 2008, pharmacists were recognised by the health departments for England, Scotland and Wales as valuable contributors to public health and disease prevention. In England, this included proposals for a bigger role in vaccination. Gareth Malson, assistant editor of Clinical Pharmacist, reports on services that are already up and running and the potential for expansion

Hepatitis C infection (Life-long learning articles)

Clinical features and diagnosis; Current and future treatments

Vaccines: an overview and update

According to the World Health Organization, the two public health interventions that have had the greatest impact on the world’s health are the supply of clean water and vaccines. This article outlines current vaccination schedules and advice